Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
MAIA
MAIA
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
MAIA News
MAIA Biotechnology Expands Phase 2 Trial for Ateganosine
Jun 10 2026
NASDAQ.COM
MAIA Biotechnology Advances THIO-101 Expansion Trial with New Clinical Site
Jun 10 2026
Newsfilter
MAIA Biotechnology Updates on Phase 3 Trial Progress
Jun 05 2026
NASDAQ.COM
MAIA's Novel Telomere Therapy Shows Strong Progress in Lung Cancer Trial
Jun 04 2026
Newsfilter
MAIA Biotechnology Receives FDA Approval for Phase 2 Trial Expansion
Jun 04 2026
NASDAQ.COM
MAIA Biotechnology Expands THIO-101 Trial with FDA Approval
Jun 03 2026
Newsfilter
MAIA Biotechnology Executives Increase Share Ownership
Jun 02 2026
Newsfilter
MAIA Biotechnology Reports Progress in THIO-101 Clinical Trial for NSCLC
Apr 16 2026
Newsfilter
MAIA Biotechnology Raises $33 Million to Advance Clinical Trials
Apr 09 2026
NASDAQ.COM
MAIA Biotechnology Secures $33 Million for Phase 3 Trial
Apr 08 2026
seekingalpha
Biotech Landscape Update: Regulatory Approvals and Acquisitions
Apr 03 2026
NASDAQ.COM
MAIA Biotechnology Reports Significant Progress in THIO-101 Trial
Apr 01 2026
NASDAQ.COM
MAIA Biotechnology Reports Breakthrough in Lung Cancer Treatment
Mar 31 2026
Newsfilter
MAIA Biotechnology Completes $30 Million Financing to Advance Clinical Development
Mar 05 2026
Yahoo Finance
U.S. Stocks Decline Amid Ongoing Iran-U.S. Conflict
Mar 03 2026
Benzinga
MAIA Biotechnology Shares Plunge 29% After $30M Offering Announcement
Mar 03 2026
seekingalpha
Show More News
